New in vitro research has demonstrated that mistletoe (viscum album) kills non small cell lung cancer cells. This research was done by the Kolisko Institute, a not -for-profit research laboratory, in cooperation with Paulina Medical Clinic doctors.

Here are some of the findings given in the research article abstract:

Non-small cell lung adenocarcinoma with EGFR mutations continues to be a vexing problem due to the ability of the cancer to rapidly develop
drug resistance. In vitro studies with the non-small cell lung adenocarcinoma cell line HCC827 (with an acquired mutation in the EGFR tyrosine
kinase domain, E746 – A750 deletion) are relevant to the finding of increasingly effective treatments. Pharmaceutically processed, extracts of
mistletoe, Viscum album Loranthaceae, have been shown since the 1920’s to have potential in cancer therapy. They are currently the most
frequently used natural preparations in complementary cancer treatments. In this pilot study we demonstrate that newly prepared standardized
extractions of mistletoe (Viscum album, L.), from different host trees, are shown to significantly diminish the cell proliferation of the HCC 827
cell line.

Another in vitro study demonstrated that mistletoe can overcome drug resistance in non small cell lung cancer cells.

An observational study showed improved lung cancer survival length after treatment with mistletoe and homeopathic remedies.

At the Paulina Medical Clinic we are using a number of mistletoe varieties that have been proven to be useful in the care of lung cancer. Among them the primary are the Iscador U.c.Hg and the abnobaViscum varieties.

Mistletoe is administered primarily in injectable but also in intravenous and oral forms. A complete protocol requires careful combining of all three. The appropriate oral drops of mistletoe are manufactured by the True Botanica company. They are not to be confused with extracts obtainable in health food stores or online.

In the care of the many patients with lung cancer that we have been involved in we have also used very specific supplements that are directed towards improving the lung physiology and strengthening the immunological response of the patient.

The results have been very encouraging.

R. Rentea MD